An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine
✍ Scribed by R. Curtis Bird; Patricia DeInnocentes; Allison E. Church Bird; Frederik W. van Ginkel; Joni Lindquist; Bruce F. Smith
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 605 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background Tumor‐associated antigens (TAAs) are known to be immunotherapy targets; thus tumor‐sharing TAA may be used as a fusion hybrid partner to confer protection against subsequent tumor challenge. ## Methods The squamous cell carcinomas (SCCs), SCCVII and B4B8, were used in C
## Abstract Several reports on immunotherapy using dendritic cells‐based vaccine have been published. We investigated findings using fusion cells (FCs) generated from rat dendritic cells and a syngeneic hepatic cancer cell line with regard to inducing anti‐tumor immunity. Vaccination of rats using